Ambrisentan Tablets and Dexmethylphenidate Extended-Release Capsules
Determining the interaction of Ambrisentan Tablets and Dexmethylphenidate Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: dexmethylphenidate
Brand name: Focalin, Focalin XR
Synonyms: Dexmethylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Dexmethylphenidate Hydrochloride
- Ambrisentan Tablets-Dexmethylphenidate Tablets
- Ambrisentan Tablets-DexPak
- Ambrisentan Tablets-DexPak 10 Day Taperpak
- Ambrisentan Tablets-DexPak 13 DayTaperpak
- Ambrisentan Tablets-DexPak 6 DayTaperpak
- Dexmethylphenidate Extended-Release Capsules-Amcinonide
- Dexmethylphenidate Extended-Release Capsules-Amcinonide Cream and Ointment
- Dexmethylphenidate Extended-Release Capsules-Amcinonide Lotion
- Dexmethylphenidate Extended-Release Capsules-Amcinonide Ointment
- Dexmethylphenidate Extended-Release Capsules-Amcinonide topical
- Dexmethylphenidate Extended-Release Capsules-Amcinonide Topical application